<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR21.html">Part 21
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 21.43  Access to requested records.
                            </h3>
                            <p class="depth1"><em>(a)</em> Access may be granted to requested records by:</p><p class="depth2"><em>(1)</em> Mailing a copy of the records to the requesting individual, or</p><p class="depth2"><em>(2)</em> Permitting the requesting individual to review the records in  person between 9 a.m. and 4 p.m. at the office of the FDA Privacy Act  Coordinator, at the Division of Freedom of Information Public Reading  Room (address is   located on the agency's web site at http://www.fda.gov), or at any Food  and Drug Administration field office, listed in part 5, subpart M of  this chapter, or at another location or time upon which the Food and  Drug Administration and the individual agree. Arrangement for such  review can be made by consultation between the FDA Privacy Act  Coordinator and the individual. An individual seeking to review records  in person shall generally be permitted access to the file copy, except  that where the records include nondisclosable information, a copy shall  be made of that portion of the records, with the nondisclosable  information blocked out. Where the individual is not given a copy of the  record to retain, no charge shall be made for the cost of copying a  record to make it available to an individual who reviews a record in  person under this paragraph.</p><p class="depth1"><em>(b)</em> An individual may request that a record be disclosed to or  discussed in the presence of another individual, such as an attorney.  The individual may be required to furnish a written statement  authorizing the disclosure or discussion in such other individual's  presence.</p><p class="depth1"><em>(c)</em> The Food and Drug Administration will make every reasonable  effort to assure that records made available under this section can be  understood by the individual, such as by providing an oral or written  explanation of the records.  [42 FR 15626, Mar. 22, 1977, as amended at 46 FR 8458, Jan. 27, 1981; 69  FR 17290, Apr. 2, 2004; 76 FR 31470, June 1, 2011; 79 FR 68115, Nov. 14,  2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
